Literature DB >> 29631229

Left adrenal ganglioneuroma: Report of a new case.

Walter Sebastián Nardi1, Sergio Damián Quildrian2.   

Abstract

INTRODUCTION: Adrenal ganglioneuroma (AGN) represents about 20% of the reported cases. PRESENTATION OF CASE: We present a 37-year-old man referred to our institution for a history of abdominal discomfort and a left adrenal solid mass incidentally discovered in CT abdominal scan (24 × 20 mm). Patient underwent laparoscopic surgical excision of the tumor.
CONCLUSION: The histopathology examination showed areas of spindle cells and scattered mature ganglionic cells compatible with AGN.
Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Adrenal ganglioneuroma; Ganglioneuroma; Laparoscopy

Year:  2018        PMID: 29631229      PMCID: PMC6000988          DOI: 10.1016/j.ijscr.2018.02.014

Source DB:  PubMed          Journal:  Int J Surg Case Rep        ISSN: 2210-2612


Introduction

Ganglioneuroma (GN) is a rare and benign neoplasm that arises from neural crest tissue [1]. Adrenal ganglioneuroma (AGN) represents about 20% of the reported cases [2]. Characteristically, GNs do not secrete catecholamines or stereoid hormones and are often clinically silent [4]. It is difficult to diagnose these tumors precisely as GN preoperatively. Definitive diagnosis is done by the histopathologic examination of the specimen. Assessment and management of these tumors are similar to other adrenal tumors. We present a patient with a ganglioneuroma of the left adrenal gland. To our knowledge this is the first report of adrenal GN in an adult patient from Argentina in the English literature. The research work has been reported in line with the SCARE criteria [1].

Presentation of case

A 37-year-old man, former smoker was referred to our department for a history of abdominal discomfort and a left adrenal solid mass incidentally discovered in CT abdominal scan. The patient was in good general status. Blood pressure and hormonal profile were within normal limits. Complete preoperative hormonal evaluation was carried out in order to evaluate functionality and the lesion was considered a non-secreting tumor. Abdominal CT showed a well-demarcated, homogeneous, hypodense, left adrenal solid mass (24 × 20 mm) with faint calcifications (Fig. 1a and b).
Fig. 1

CT-scan showing a left adrenal solid mass.

CT-scan showing a left adrenal solid mass. After a multidisciplinary committee evaluation surgical resection was recommended because of the impossibility to rule out malignancy. Laparoscopic approach was done and the abdominal cavity was explored showing no abnormalities. After surgical diesection a solid nodule in the left adrenal gland was found (Fig. 2a). Adrenal vessels were identified and complete excision was done (Fig. 2b). Postoperative course was uneventful being discharged on postoperative day 1.
Fig. 2

A: Solid tumor in left adrenal gland. B: Left adrenal vein. C-D: Microscopically, features include mature ganglion cells admixed with clusters of spindle cells.

A: Solid tumor in left adrenal gland. B: Left adrenal vein. C-D: Microscopically, features include mature ganglion cells admixed with clusters of spindle cells. Gross examination showed an encapsulated solid mass of 2,5 × 2 cm while microscopic examination showed areas of spindle cells (positive for S-100 protein in inmunohistochemical staining) and scattered mature ganglionic cells. Diagnosis of ganglioneuroma of the adrenal gland was made (Fig. 2c and d).

Discussion

Ganglioneuroma is a rare, benign, differentiated neurogenic tumor that arises in neural crest cells [1]. The most common locations of GNs are posterior mediastinum and retroperitoneum. Adrenal ganglioneuroma occurs more frequently in children and young adults such as in our patient. It has benign histology and biologic behaviour with no hormonal secretion. Adrenal ganglioneuromas are usually found to be silent and are incidentally discovered. In most cases AGNs are asymptomatic because of the nonhormone secreting nature of the tumor [[7], [8]]. They may occasionally secrete catecholamines [3]. Some studies have demonstrated that GNs are not associated with endocrine hormonal activity [[4], [5], [6]] but is expected to be found if as a composite tumor with pheochromocytoma [2]. Characteristically AGNs appear as well-defined masses with fibrous shapes on CT-scans. They present low attenuation on precontrast phase with increase in the postcontrast phase. Homogenous appearance in precontrast phase and heterogeneous in postcontrast phase is also another characteristic of neurogenic tumors [8]. The presence of punctate calcifications with no vessel involvement and low precontrast attenuation on CT should lead the physician to consider GN as a possible diagnosis [7]. Adrenal adenomas have homogeneous morphology similar to AGN, however, are often small and present washout of more than 50% contrast on postcontrast phase [9]. Macroscopically, GNs are encapsulated solid masses with homogeneous grayish surface. Microscopically, features include mature ganglion cells admixed with clusters of spindle cells (positive for S-100 protein) [[2], [5], [7]].

Conclusion

AGNs are rare tumors and, despite some clues for radiologic diagnosis, preoperative diagnosis is difficult. Therefore, complete resection is recommended once malignancy cannot be excluded.

Conflict of interest

None.

Funding

None.

Ethical approval

The study is exempt from ethical approval in our institution.

Consent

Written informed consent was obtained from the patient and there are no alterations that distort scientific meaning. Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request.

Authors contribution

Nardi: Operated and managed the patient. Study design. Quildrian: Operated and managed the patient. Study design.

Guarantor

Nardi and Quildrian.
  8 in total

1.  Clinicopathological Features of Ganglioneuroma Originating From the Adrenal Glands.

Authors:  Joon-Hyop Lee; Young Jun Chai; Tae-Hyung Kim; June Young Choi; Kyu Eun Lee; Hyun-Young Kim; Yoo-Seok Yoon; Hyeon Hoe Kim
Journal:  World J Surg       Date:  2016-12       Impact factor: 3.352

Review 2.  Incidental adrenal lesions: principles, techniques, and algorithms for imaging characterization.

Authors:  Giles W L Boland; Michael A Blake; Peter F Hahn; William W Mayo-Smith
Journal:  Radiology       Date:  2008-12       Impact factor: 11.105

3.  Adrenal and extra-adrenal retroperitoneal ganglioneuroma: imaging findings in 13 adults.

Authors:  R Radin; C L David; H Goldfarb; I R Francis
Journal:  Radiology       Date:  1997-03       Impact factor: 11.105

4.  Adrenal ganglioneuroma. A neoplasia to exclude in patients with adrenal incidentaloma.

Authors:  S Maweja; R Materne; N Detrembleur; L de Leval; Th Defechereux; M Meurisse; E Hamoir
Journal:  Acta Chir Belg       Date:  2007 Nov-Dec       Impact factor: 1.090

5.  Adrenal ganglioneuromas: a 10-year experience in a Chinese population.

Authors:  Yang Qing; Xu Bin; Wang Jian; Gao Li; Wang Linhui; Liu Bing; Wang Huiqing; Sun Yinghao
Journal:  Surgery       Date:  2010-01-12       Impact factor: 3.982

6.  Adrenal ganglioneuroma: report of a new case.

Authors:  Cihangir Erem; Ozge Ucuncu; Irfan Nuhoglu; Akif Cinel; Umit Cobanoglu; Adem Demirel; Ekrem Koc; Mustafa Kocak; Gulname Findik Guvendi
Journal:  Endocrine       Date:  2009-04-15       Impact factor: 3.633

7.  Adrenal ganglioneuroma: features and outcomes of 27 cases at a referral cancer centre.

Authors:  Hassan Shawa; Khaled M Elsayes; Sanaz Javadi; Ajaykumar Morani; Michelle D Williams; Jeffrey E Lee; Steven G Waguespack; Naifa L Busaidy; Rena Vassilopoulou-Sellin; Camilo Jimenez; Mouhammed Amir Habra
Journal:  Clin Endocrinol (Oxf)       Date:  2013-09-18       Impact factor: 3.478

8.  Adrenal ganglioneuroma.

Authors:  Sylvie Maweja; Roland Materne; Nancy Detrembleur; Laurence de Leval; Thierry Defechereux; Michel Meurisse; Etienne Hamoir
Journal:  Am J Surg       Date:  2007-11       Impact factor: 2.565

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.